# Effect of Dosing Time and Meal on IN-105 (Insulin Tregopil) PK and PD

> **NCT03392961** · PHASE1 · COMPLETED · sponsor: **Biocon Limited** · enrollment: 51 (actual)

## Conditions studied

- Type 2 Diabetes Mellitus

## Interventions

- **DRUG:** IN-105 (Insulin Tregopil)
- **OTHER:** Placebo comparator

## Key facts

- **NCT ID:** NCT03392961
- **Lead sponsor:** Biocon Limited
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-03-27
- **Primary completion:** 2014-07-01
- **Final completion:** 2014-07-01
- **Target enrollment:** 51 (ACTUAL)
- **Last updated:** 2018-01-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03392961

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03392961, "Effect of Dosing Time and Meal on IN-105 (Insulin Tregopil) PK and PD". Retrieved via AI Analytics 2026-06-14 from https://api.ai-analytics.org/clinical/NCT03392961. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*